Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs.

Howe LR, Lippman SM.

J Natl Cancer Inst. 2008 Oct 15;100(20):1420-3. doi: 10.1093/jnci/djn347. Epub 2008 Oct 7. No abstract available.

2.

Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer.

Harris RE, Kasbari S, Farrar WB.

Oncol Rep. 1999 Jan-Feb;6(1):71-3.

PMID:
9864404
3.

Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis.

Zhao YS, Zhu S, Li XW, Wang F, Hu FL, Li DD, Zhang WC, Li X.

Breast Cancer Res Treat. 2009 Sep;117(1):141-50. doi: 10.1007/s10549-008-0228-6. Epub 2008 Nov 2. Review.

PMID:
18979210
4.

Non-steroidal anti-inflammatory drugs in chemoprevention of breast and prostate cancer.

Badawi AF, El-Sohemy A.

Med Hypotheses. 2001 Aug;57(2):167-8.

PMID:
11461166
5.

Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer.

Rahme E, Ghosn J, Dasgupta K, Rajan R, Hudson M.

BMC Cancer. 2005 Dec 12;5:159.

6.

Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.

Takkouche B, Regueira-Méndez C, Etminan M.

J Natl Cancer Inst. 2008 Oct 15;100(20):1439-47. doi: 10.1093/jnci/djn324. Epub 2008 Oct 7.

PMID:
18840819
7.
8.

Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk.

Shen J, Gammon MD, Terry MB, Teitelbaum SL, Neugut AI, Santella RM.

Breast Cancer Res. 2006;8(6):R71.

9.

Breast cancer and NSAID use: heterogeneity of effect in a case-control study.

Harris RE, Namboodiri K, Stellman SD, Wynder EL.

Prev Med. 1995 Mar;24(2):119-20. No abstract available.

PMID:
7597011
10.

Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer.

Johnson TW, Anderson KE, Lazovich D, Folsom AR.

Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1586-91.

11.

Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast.

Moorman PG, Grubber JM, Millikan RC, Newman B.

Cancer Causes Control. 2003 Dec;14(10):915-22.

PMID:
14750530
12.

The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer.

Coogan PF, Rao SR, Rosenberg L, Palmer JR, Strom BL, Zauber AG, Stolley PD, Shapiro S.

Prev Med. 1999 Aug;29(2):72-6.

PMID:
10446030
13.

Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study.

Friis S, Thomassen L, Sørensen HT, Tjønneland A, Overvad K, Cronin-Fenton DP, Vogel U, McLaughlin JK, Blot WJ, Olsen JH.

Eur J Cancer Prev. 2008 Apr;17(2):88-96. doi: 10.1097/CEJ.0b013e3282b6fd55.

PMID:
18287865
14.

Nonsteroidal anti-inflammatory drugs and esophageal inflammation - Barrett's esophagus - adenocarcinoma sequence: a meta-analysis.

Wang F, Lv ZS, Fu YK.

Dis Esophagus. 2011 Jul;24(5):318-24. doi: 10.1111/j.1442-2050.2010.01153.x. Epub 2010 Dec 17. Review.

PMID:
21166737
15.

Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.

Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A; Women's Health Initiative.

Cancer Res. 2003 Sep 15;63(18):6096-101.

16.

Prospective study of regular aspirin use and the risk of breast cancer.

Egan KM, Stampfer MJ, Giovannucci E, Rosner BA, Colditz GA.

J Natl Cancer Inst. 1996 Jul 17;88(14):988-93.

PMID:
8667430
17.

Nonsteroidal antiinflammatory drugs and breast cancer.

Harris RE, Namboodiri KK, Farrar WB.

Epidemiology. 1996 Mar;7(2):203-5.

PMID:
8834563
18.

Clinical evidence of the relationship between aspirin and breast cancer risk (review).

Jacobo-Herrera NJ, Pérez-Plasencia C, Camacho-Zavala E, González GF, Urrutia EL, García-Castillo V, Zentella-Dehesa A.

Oncol Rep. 2014 Aug;32(2):451. doi: 10.3892/or.2014.3270. Epub 2014 Jun 13. Review.

PMID:
24927467
19.

Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study.

Gierach GL, Lacey JV Jr, Schatzkin A, Leitzmann MF, Richesson D, Hollenbeck AR, Brinton LA.

Breast Cancer Res. 2008;10(2):R38. doi: 10.1186/bcr2089. Epub 2008 Apr 30.

20.

Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?

Tan XL, Nieters A, Hoffmeister M, Beckmann L, Brenner H, Chang-Claude J.

Pharmacogenet Genomics. 2007 Aug;17(8):639-45.

PMID:
17622940

Supplemental Content

Support Center